Betahistine
Betahistine is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 60.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
Interventions for Residual Dizziness After Successful Repositioning Maneuvers in Patients With BPPV
Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
The Effect of Betahistine on Body Weight in Obese Subjects
Clinical Trials (7)
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
Interventions for Residual Dizziness After Successful Repositioning Maneuvers in Patients With BPPV
Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
The Effect of Betahistine on Body Weight in Obese Subjects
Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects
A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7